$CYAB

CYABRA, INC.

CIK:0002032341|SEC Filings

Condensed Consolidated Interim Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenues	$ 1,853	$ 1,331	$ 3,268	$ 2,591
Cost of revenues	304	213	496	409
Gross profit	1,549	1,118	2,772	2,182
Operating costs and expenses
Research and development expenses	2,060	1,840	7,568	3,691
Sales and marketing expenses	1,304	1,456	2,559	3,192
General and administrative expenses	1,305	1,241	7,589	2,756
Total operating loss	(3,120)	(3,419)	(14,944)	(7,457)
Finance income (expenses)	(255)	992	799	1,716
Loss before taxes on income	(3,375)	(2,427)	(14,145)	(5,741)
Taxes on income	64	19	64	19
Net loss for the period	$ (3,439)	$ (2,446)	$ (14,209)	$ (5,760)
Loss per share attributable to common shareholders
Basic loss per share	$ (0.26)	$ (1.07)	$ (1.68)	$ (2.53)
Diluted loss per share	$ (0.26)	$ (1.07)	$ (1.78)	$ (2.53)
Weighted average number of common stock outstanding used in computation of basic loss per share	13,390,609	2,435,385	8,458,222	2,396,328
Weighted average number of common stock outstanding used in computation of diluted loss per share	13,790,609	2,435,385	8,669,333	2,396,328

Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows – operating activities
Net loss for the period	$ (14,209)	$ (5,760)
Adjustments:
Depreciation	29	29
Interest expense	124	18
Payment of previously accrued interest	(126)
Share based payments	4,431	2,255
Share based payments for advisory services	1,009
Shares issued to advisors	2,100
Exchange rate differences	50	11
Revaluation of financial liabilities accounted at fair value	(1,369)	(1,671)
Changes in operating assets and liabilities:
Increase in other assets	(351)	(37)
Increase in accounts receivable	(299)	(169)
Increase in trade accounts payable	829	679
Change in ROU asset and lease liability	5	31
Increase in deferred revenues	1,204	670
Increase in employees and related	1,639	275
Decrease in other current liabilities	(61)	(164)
Net cash used in operating activities	(4,995)	(3,833)
Cash flows – investing activity
Purchase of property and equipment	(28)	(29)
Net cash used in investing activity	(28)	(29)
Cash flows – financing activities
Receipt of loans	2,655	1,613
Repayment of loans	(6,430)	(915)
Exercise of options	3	2
Cash received from Merger Agreement upon the effectiveness of the Business Combination	1,336
Proceeds from PIPE, net of transaction costs	8,000
Issuance of preferred shares, net		2,431
Net cash provided by financing activities	5,564	3,131
Increase (decrease) in cash, cash equivalents and restricted cash	541	(731)
Exchange rate differences on cash and cash equivalents and restricted cash	(39)	(11)
Cash, cash equivalents and restricted cash at the beginning of period	316	946
Cash, cash equivalents and restricted cash at the end of the period	818	204
Supplemental Disclosures of cash flow information:
Interest paid	249	57
Supplemental disclosure of non-cash activity:
Conversion of redeemable preferred shares	15,268
Conversion of convertible notes	12,676
Conversion of warrant liability to equity	390
Share issued to advisors	2,112
Right of use asset recognized with corresponding lease liability		296
Purchase of property and equipment		20
Conversion of SAFE		1,057
Cash, cash equivalent and restricted cash at the end of the period:
Cash and cash equivalents	794	183
Restricted cash	$ 24	$ 21

Condensed Consolidated Interim Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 794	$ 294
Restricted cash	24	22
Accounts receivable	568	269
Other current assets	593	152
Total current assets	1,979	737
Non-Current Assets
Operating right-of-use asset	410	575
Property and equipment, net	144	146
Other assets	99
Total non-current assets	653	721
Total Assets	2,632	1,458
Current liabilities
Trade accounts payable	2,015	1,775
Accrued expenses	1,812	476
Short term loans	2,003	5,768
Operating lease liability	392	380
Deferred revenues	3,452	2,816
Employees and related	2,937	1,298
Other current liabilities	1,206	94
Convertible notes		12,869
Liability with respect to warrants	33
Total current liabilities	13,850	25,476
Non-Current Liabilities
Operating lease liability	95	268
Long-term deferred revenues	683	115
Liability with respect to warrants		370
Total non-current liabilities	778	753
Total liabilities	14,628	26,229
Commitments and contingent liabilities
Capital Deficiency:
Additional paid in capital	49,584	7,332
Accumulated deficit	(61,582)	(47,373)
Total capital deficiency	(11,996)	(40,039)
Total liabilities, redeemable convertible preferred shares and capital deficiency	2,632	1,458
Class A common stock
Capital Deficiency:
Class A common stock	2	2
Redeemable Convertible Preferred Shares
Redeemable Convertible Preferred Shares:
Preferred shares, value		15,268
Series A Convertible Preferred Stock
Capital Deficiency:
Preferred Stock, value
Series B Convertible Preferred Stock
Capital Deficiency:
Preferred Stock, value
Series C Convertible Preferred Stock
Capital Deficiency:
Preferred Stock, value